Profile data is unavailable for this security.
About the company
Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
- Revenue in EUR (TTM)455.20m
- Net income in EUR28.56m
- Incorporated1967
- Employees2.77k
- LocationBoiron SA2 avenue de l ouest LyonnaisRONTALON 69510FranceFRA
- Phone+33 478456100
- Fax+33 478456291
- Websitehttp://www.boiron.fr/
More ▼
Mergers & acquisitions
| Acquired company | BOI:PAR since announced | Transaction value |
|---|---|---|
| Abbi Sas | 29.66% | 1.98m |
Data delayed at least 15 minutes, as of Aug 19 2022 14:01 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eurobio Scientific SA | 184.71m | 60.54m | 214.84m | 165.00 | 3.40 | 1.33 | 3.12 | 1.15 | 5.53 | 5.53 | 16.90 | 14.17 | 0.9667 | 5.65 | 3.85 | 1,119,467.00 | 31.69 | 24.13 | 40.62 | 34.46 | 55.35 | 50.52 | 32.78 | 23.66 | 4.36 | 72.29 | 0.0924 | 0.00 | -2.19 | 46.13 | -17.61 | -- | 55.99 | -- |
| Innate Pharma SA | 12.11m | -45.48m | 215.02m | 215.00 | -- | 2.03 | -- | 18.03 | -0.572 | -0.6634 | 0.1523 | 1.35 | 0.0421 | -- | 2.12 | 56,334.88 | -15.82 | -6.65 | -20.23 | -9.58 | 74.69 | 92.81 | -375.48 | -45.00 | -- | -- | 0.4407 | -- | -78.43 | -26.42 | -5,385.89 | -- | -32.35 | -- |
| Transgene SA | 17.01m | -19.54m | 217.44m | 167.00 | -- | 3.20 | -- | 12.96 | -0.219 | -0.219 | 0.1867 | 0.6874 | 0.1817 | -- | 2.88 | 101,880.20 | -20.86 | -15.27 | -24.56 | -18.27 | -- | -- | -114.82 | -147.28 | -- | -- | 0.0541 | -- | 82.10 | 14.28 | -13.38 | -- | 90.14 | -- |
| Genfit SA | 85.58m | 67.26m | 221.58m | 112.00 | 4.21 | 1.88 | 3.20 | 2.62 | 1.07 | 1.07 | 1.54 | 2.39 | 0.3563 | 367.75 | 201.84 | 764,098.20 | 28.01 | -18.67 | 34.81 | -21.82 | 98.28 | 93.39 | 78.59 | -157.66 | 4.27 | -- | 0.3735 | -- | 1,003.11 | 66.03 | 166.45 | -- | -23.40 | -- |
| Guerbet SA | 732.07m | 32.64m | 257.88m | 2.73k | 7.96 | 0.6407 | 2.93 | 0.3549 | 2.58 | 2.58 | 57.87 | 32.08 | 0.7522 | 0.9393 | 6.37 | 268,157.90 | 3.35 | 3.62 | 4.32 | 5.04 | 73.92 | 75.55 | 4.46 | 4.70 | 1.24 | 6.05 | 0.4516 | 27.45 | 2.78 | -1.15 | 78.93 | 2.44 | -0.3443 | 0.00 |
| Carbios SA | 105.00k | 3.78m | 339.34m | 59.00 | 89.14 | 2.38 | 45.57 | 3,323.39 | 0.35 | 0.35 | 0.0096 | 13.13 | 0.0009 | -- | 0.9767 | 1,779.66 | 4.14 | -5.46 | 4.44 | -5.96 | -701.90 | -- | 4,675.24 | -316.96 | -- | 10.90 | 0.0844 | -- | -17.97 | -58.82 | 145.69 | -5.14 | 107.86 | -- |
| AB Science SA | 1.61m | -14.46m | 370.19m | 98.00 | -- | -- | -- | 233.86 | -0.3029 | -0.3029 | 0.0338 | -0.4363 | 0.0631 | 1.01 | 4.83 | 16,397.96 | -56.76 | -69.55 | -265.60 | -203.89 | 93.09 | 91.10 | -899.94 | -1,273.48 | 1.03 | -321.12 | -- | -- | 1.52 | 1.28 | 3.87 | -- | 1.48 | -- |
| DBV Technologies SA | 5.54m | -95.22m | 482.04m | 226.00 | -- | -- | -- | 86.37 | -1.74 | -1.74 | 0.1012 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1,717.80 | -1,272.93 | -- | -586.89 | -- | -- | -49.38 | -10.69 | 38.59 | -- | -- | -- |
| Boiron SA | 455.20m | 28.56m | 833.41m | 2.77k | 28.90 | 1.55 | 19.52 | 1.82 | 1.63 | 1.63 | 25.99 | 30.36 | 0.5864 | 1.50 | 4.89 | 164,391.80 | 3.68 | 5.96 | 4.69 | 7.50 | 71.97 | 76.84 | 6.27 | 8.41 | 2.32 | -- | 0.0232 | 46.86 | -11.37 | -5.82 | 8.95 | -18.15 | -10.06 | -9.90 |
| Valneva SE | 346.72m | -71.76m | 1.19bn | 722.00 | -- | 7.38 | 56.38 | 3.44 | -0.7206 | -0.7206 | 3.42 | 1.38 | 0.513 | 1.58 | 13.82 | 480,218.80 | -10.62 | -8.98 | -21.48 | -12.92 | 46.03 | 53.98 | -20.70 | -18.41 | 1.12 | -2.63 | 0.4377 | -- | 215.52 | 29.91 | -14.03 | -- | 90.83 | -- |
| Vetoquinol SA | 521.27m | 62.86m | 1.45bn | 2.55k | 23.33 | 3.32 | 16.29 | 2.83 | 5.31 | 5.31 | 44.07 | 37.30 | 0.8205 | 2.61 | 5.93 | 204,741.60 | 9.88 | 6.97 | 14.35 | 9.18 | 50.68 | 61.10 | 12.04 | 8.78 | 1.03 | -- | 0.0337 | 15.15 | 21.94 | 8.27 | 227.04 | 17.70 | 18.97 | 13.22 |
| Euroapi SAS | -100.00bn | -100.00bn | 1.53bn | 3.34k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.48 | -- | -150.79 | -- | -- | -- |
| Virbac SA | 1.06bn | 113.16m | 3.10bn | 5.10k | 27.43 | 4.28 | 19.57 | 2.92 | 13.40 | 13.40 | 125.95 | 85.82 | 0.9208 | 2.32 | 10.18 | 207,805.70 | 10.00 | 5.26 | 14.49 | 7.54 | 47.50 | 47.46 | 10.86 | 7.10 | 0.9557 | 20.29 | 0.1153 | 5.31 | 13.89 | 4.06 | -16.82 | 26.71 | 3.33 | -- |
Data as of Aug 19 2022. Currency figures normalised to Boiron SA's reporting currency: Euro EUR
13.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Natixis Investment Managers International SAas of 31 Dec 2021 | 1.01m | 5.78% |
| Financi�re de l'�chiquier SAas of 31 Dec 2021 | 439.37k | 2.50% |
| Sycomore Asset Management SAas of 30 Sep 2021 | 199.93k | 1.14% |
| Amiral Gestion SAas of 31 Dec 2021 | 140.99k | 0.80% |
| BlackRock Fund Advisorsas of 03 Aug 2022 | 106.52k | 0.61% |
| Dimensional Fund Advisors LPas of 04 Aug 2022 | 96.59k | 0.55% |
| Norges Bank Investment Managementas of 31 Dec 2021 | 83.48k | 0.48% |
| The Vanguard Group, Inc.as of 05 Aug 2022 | 78.53k | 0.45% |
| SMA Gestion SAas of 30 Jun 2021 | 76.17k | 0.43% |
| Gay-Lussac Gestion SAas of 31 Dec 2021 | 47.50k | 0.27% |
More ▼
Data from 30 Jun 2021 - 30 Jun 2022Source: FactSet Research Systems Inc.
